| Mar 17, 2015
| 10:39 AM
The $70-billion purchase of Botox maker Allergan Inc. of Irvine by Irish company Actavis has closed, Actavis confirmed Tuesday.
Allergan’s longtime leader, David E.I. Pyott, will not have a position in the new company, which will be called...
| Feb 10, 2015
| 2:51 PM
After less than two years on the job, Office Depot CEO Roland Smith could receive $39 million if the Staples-Office Depot merger is finalized, executive pay experts say.
Smith, 60, would leave with a $7 million severance, roughly twice his salary and...
| Dec 16, 2014
| 7:12 PM
The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO.
Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...
| Nov 17, 2014
| 8:30 PM
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.
The deal thwarts a...
| Jun 10, 2014
| 12:02 PM
The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution.
Valeant Pharmaceuticals International Inc. last month...
| Oct 27, 2014
| 5:10 PM
As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm.
J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
| Oct 9, 2014
| 8:22 AM
Botox maker Allergan lifted its profit outlook Thursday as it tries to stave off a takeover attempt from a Canadian rival.
The Irvine-based drug maker said it expects to earn between $1.76 and $1.78 a share during the third quarter, up from its previous...
| May 28, 2014
| 5:37 PM
For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts.
After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
| May 6, 2014
| 6:57 PM
The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders.
Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
| May 12, 2014
| 9:59 AM
Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders.
Last month, the Irvine drugmaker received an...
| May 12, 2014
| 7:51 PM
Botox maker Allergan Inc. rejected a $46-billion takeover offer from a Canadian rival, setting the stage for what analysts said may become a long and nasty fight for control of the Irvine company and its prized collection of eye and skin medications....